Clincosm LogoSign in Get a demo

Allosensitization

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

Not yet recruiting
  • Antibody-mediated Rejection
  • Allosensitization
  • New York, New York
    NYU Langone Health
May 16, 2023

Allosensitization, Heart Transplant Failure and Rejection Trial in Stanford (Daratumumab-SC)

Recruiting
  • Allosensitization
  • Heart Transplant Failure and Rejection
  • Stanford, California
    Stanford Health Care
Sep 20, 2021

Allosensitization, Heart Transplant Failure and Rejection Trial (Daratumumab)

Withdrawn
  • Allosensitization
  • Heart Transplant Failure and Rejection
  • (no location specified)
Oct 26, 2020

Allosensitization, Kidney Transplant Rejection, Antibody-mediated Rejection Trial in Créteil (Daratumumab dose escalation,

Recruiting
  • Allosensitization
  • +2 more
  • Daratumumab dose escalation
  • Daratumumab full dose
  • Créteil, France
    Henri Mondor
May 19, 2020

Kidney Transplant Failure, Allosensitization, Immunosuppression Trial in London (Envarsus Oral Product)

Recruiting
  • Kidney Transplant Failure
  • +2 more
  • Envarsus Oral Product
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Feb 27, 2019